Clinical Trial: Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07183852) titled 'Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma' on Sept. 12.

Brief Summary: The purpose of this study is to evaluate the feasibility, safety and tolerability of locoregional or systemic administration of autologous tumor infiltrating lymphocytes in patients with metastatic melanoma

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Metastatic Uveal Melanoma Metastatic Cutaneous Melanoma

Intervention: DRUG: Autologous Tumor Infiltrating Lymphocytes (TIL)

Cohort 1: Administered via hepatic arterial infusion Cohort 2: Administered via in...